Evidence map›Paper›PMID 33578223›Full record

ReviewEpilepsy & behavior : E&B2021

Climate change and epilepsy: Insights from clinical and basic science studies.

Medine I Gulcebi, Emanuele Bartolini, Omay Lee, Christos Panagiotis Lisgaras, Filiz Onat, Janet Mifsud, Pasquale Striano, Annamaria Vezzani, Michael S Hildebrand, Diego Jimenez-Jimenez and 10 more

Open access · greenAbstract readReview
In one paragraph

Review in Epilepsy & behavior : E&B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Medications, epilepsy and climate change: Added layers of complexity.British journal of clinical pharmacology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Epilepsy grand challenge 2025.Frontiers in neurology · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 20 institutions in 8 countries.

Medine I GulcebiDepartment of Medical Pharmacology, Marmara University, School of Medicine, Istanbul, Turkey.
Emanuele BartoliniUSL Centro Toscana, Neurology Unit, Nuovo Ospedale Santo Stefano, Via Suor Niccolina Infermiera 20, 59100 Prato, Italy. Electronic address: emanuele.bartolini@uslcentro.toscana.it.
Omay LeeDepartment of Neurology and Clinical Neurophysiology, St. George's University Hospitals NHS Foundation Trust, London, UK. Electronic address: omay@doctors.org.uk.
Christos Panagiotis LisgarasNew York University Langone Health, 100 First Ave., New York, NY 10016, USA; The Nathan S. Kline Institute for Psychiatric Research, Center for Dementia Research, 140 Old Orangeburg Rd., Orangeburg, NY 10962, USA. Electronic address: Christos.Lisgaras@nyulangone.org.
Filiz OnatDepartment of Medical Pharmacology, Marmara University School of Medicine, Istanbul, Turkey; Department of Medical Pharmacology, Acibadem University School of Medicine, Istanbul, Turkey.
Janet MifsudDepartment of Clinical Pharmacology and Therapeutics, University of Malta, Msida MSD2040, Malta. Electronic address: Janet.mifsud@um.edu.mt.
Pasquale StrianoPaediatric Neurology and Muscular Diseases Unit, DINOGMI-Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, IRCCS "Giannina Gaslini" Institute, Genova, Italy.
Annamaria VezzaniLaboratory of Experimental Neurology, Department of Neuroscience, IRCCS 'Mario Negri' Institute for Pharmacological Research, Milan, Italy. Electronic address: annamaria.vezzani@marionegri.it.
Michael S HildebrandDepartment of Medicine (Austin Health), University of Melbourne, and Murdoch Children's Research Institute, Melbourne, Victoria, Australia. Electronic address: michael.hildebrand@unimelb.edu.au.
Diego Jimenez-JimenezDepartment of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK and Chalfont Centre for Epilepsy, Bucks, UK. Electronic address: diego.jimenez@ucl.ac.uk.
Larry JunckDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA. Electronic address: ljunck@med.umich.edu.edu.
David Lewis-SmithTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK. Electronic address: david.lewis-smith@newcastle.ac.uk.
Ingrid E SchefferUniversity of Melbourne, Austin Health and Royal Children's Hospital, Florey Institute and Murdoch Children's Research Institute, Melbourne, Australia. Electronic address: i.scheffer@unimelb.edu.au.
Roland D ThijsDepartment of Neurology, Leiden University Medical Centre (LUMC), PO Box 9600, 2300 RC Leiden, the Netherlands. Electronic address: rthijs@sein.nl.
Sameer M ZuberiPaediatric Neurosciences Research Group, Royal Hospital for Children & Institute of Health & Wellbeing, University of Glasgow, Fraser of Allander Neurosciences Unit, Royal Hospital for Children, UK. Electronic address: sameer.zuberi@nhs.net.
Stephen BlenkinsopSchool of Engineering, Newcastle University, Newcastle upon Tyne, UK. Electronic address: stephen.blenkinsop@newcastle.ac.uk.
Hayley J FowlerCentre for Earth Systems Engineering Research, School of Engineering, Newcastle University, UK. Electronic address: hayley.fowler@newcastle.ac.uk.
Aideen FoleyDepartment of Geography, Birkbeck College University of London, London, UK. Electronic address: a.foley@bbk.ac.uk.
Epilepsy Climate Change Consortium
Sanjay M SisodiyaDepartment of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK and Chalfont Centre for Epilepsy, Bucks, UK. Electronic address: s.sisodiya@ucl.ac.uk.
Newcastle University · GBLeiden University · NLEpilepsy Research UK · GBMario Negri Institute for Pharmacological Research · ITAcıbadem University · TRAzienda Usl Toscana Centro · ITBirkbeck, University of London · GBIstituto Giannina Gaslini · ITLeiden University Medical Center · NLMarmara University · TRNathan Kline Institute for Psychiatric Research · USNational Hospital for Neurology and Neurosurgery · GBOslo University Hospital · NORoyal Children's Hospital · AURoyal Hospital for Children · GBSt George’s University Hospitals NHS Foundation Trust · GBThe University of Melbourne · AUUnited States Congress · USUniversity of Malta · MTUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Climate change is with us. As professionals who place value on evidence-based practice, climate change is something we cannot ignore. The current pandemic of the novel coronavirus, SARS-CoV-2, has demonstrated how global crises can arise suddenly and have a significant impact on public health. Global warming, a chronic process punctuated by acute episodes of extreme weather events, is an insidious global health crisis needing at least as much attention. Many neurological diseases are complex chronic conditions influenced at many levels by changes in the environment. This review aimed to collate and evaluate reports from clinical and basic science about the relationship between climate change and epilepsy. The keywords climate change, seasonal variation, temperature, humidity, thermoregulation, biorhythm, gene, circadian rhythm, heat, and weather were used to search the published evidence. A number of climatic variables are associated with increased seizure frequency in people with epilepsy. Climate change-induced increase in seizure precipitants such as fevers, stress, and sleep deprivation (e.g. as a result of more frequent extreme weather events) or vector-borne infections may trigger or exacerbate seizures, lead to deterioration of seizure control, and affect neurological, cerebrovascular, or cardiovascular comorbidities and risk of sudden unexpected death in epilepsy. Risks are likely to be modified by many factors, ranging from individual genetic variation and temperature-dependent channel function, to housing quality and global supply chains. According to the results of the limited number of experimental studies with animal models of seizures or epilepsy, different seizure types appear to have distinct susceptibility to seasonal influences. Increased body temperature, whether in the context of fever or not, has a critical role in seizure threshold and seizure-related brain damage. Links between climate change and epilepsy are likely to be multifactorial, complex, and often indirect, which makes predictions difficult. We need more data on possible climate-driven altered risks for seizures, epilepsy, and epileptogenesis, to identify underlying mechanisms at systems, cellular, and molecular levels for better understanding of the impact of climate change on epilepsy. Further focussed data would help us to develop evidence for mitigation methods to do more to protect people with epilepsy from the effects of climate change.

Indexed as

Climate ChangeAnimalsCOVID-19Death, SuddenEpilepsyGlobal HealthHot TemperatureHumansHumidityPublic HealthSleep DeprivationWeatherEmergencyExtreme weather eventsGlobal warmingPublic healthSeizureTemperature

Identifiers

PMID33578223
PMCPMC9386889
OpenAlexW3127212737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.